endoHPB
Efficacy and Safety of Endobiliairy Radiofrequency (Probe Habib TM EndoHPB) for the Destruction of Residual Endo Biliairy Dysplastic Buds After Endoscopic Ampullectomy: Prospective Multicenter Study
Sponsor study identifier
interventional
20
0 countries
N/A
Study Start
November 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2017
Actual (reported)Study Completion
March 2017
Actual (reported)The purpose of the study is to assess the efficacy and morbidity of biliairy radiofrequency ablation for the treatment of dysplastic endobiliairy residual lesions (low-grade dysplasia or high-grade dysplasia) after endoscopic ampullectomy for ampullary adenoma.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2017
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2012
Date type not reportedThis date has not been verified as actual or estimated.
June 15, 2016
Actual (reported)July 7, 2016
Actual (reported)March 2017
Actual (reported)March 2017
Actual (reported)number of residual neoplasia
one year
presence of low grade dysplasia or high grade dysplasia or invasive carcinoma
6 months
number of surgery
one year
fever
48 hours post endoscopic procedure
pain
48 hours post endoscopic procedure
bleeding
48 hours post endoscopic procedure
During an endoscopic retrograde cholangiography, endobiliary application of radiofrequency through a dedicated probe named Habib.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Camus M, Napoleon B, Vienne A, Le Rhun M, Leblanc S, Barret M, Chaussade S, Robin F, Kaddour N, Prat F. Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy: a multicenter prospective study. Gastrointest Endosc. 2018 Sep;88(3):511-518. doi: 10.1016/j.gie.2018.04.2332. Epub 2018 Apr 13.
20 participants (actual enrollment reported by the registry).
First Submitted
June 15, 2016
First Posted
July 7, 2016
Study Start
November 2012
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
March 2017
Actual (reported)Study Completion
March 2017
Actual (reported)Last Updated
August 28, 2017
Record last verified: 2017-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: